{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:00:04Z","timestamp":1781290804519,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jbspin.2023.105524","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T11:31:05Z","timestamp":1673004665000},"page":"105524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series"],"prefix":"10.1016","volume":"90","author":[{"given":"Sara","family":"Bindoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sfriso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2023.105524_bib0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40265-018-0956-9","article-title":"Adult-onset Still's disease: molecular pathophysiology and therapeutic advances","volume":"78","author":"Sfriso","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jbspin.2023.105524_bib0120","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2017.00131","article-title":"Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure","volume":"8","author":"Cavalli","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0130","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jbspin.2023.105524_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2023.105524_bib0145","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0150","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0155","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/asheducation-2015.1.190","article-title":"Treatment of hemophagocytic lymphohistiocytosis in adults","volume":"2015","author":"La Ros\u00e9e","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jbspin.2023.105524_bib0165","doi-asserted-by":"crossref","first-page":"603389","DOI":"10.3389\/fimmu.2020.603389","article-title":"Cytokine storm in coronavirus disease 2019 and adult-onset Still's disease: similarities and differences","volume":"11","author":"Meng","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0170","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41590-021-00901-9","article-title":"Lessons learned: new insights on the role of cytokines in COVID-19","volume":"22","author":"Buszko","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0175","series-title":"EMA recommends approval for use of Kineret in adults with COVID-19","author":"European Medicine Agency","year":"2021"},{"key":"10.1016\/j.jbspin.2023.105524_bib0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijid.2020.11.149","article-title":"Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study","volume":"103","author":"Balkhair","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jbspin.2023.105524_bib0185","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/rheumatology\/keab447","article-title":"Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"60","author":"Barkas","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2023.105524_bib0190","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0195","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4049\/jimmunol.2001126","article-title":"Il-1 receptor antagonist anakinra in the treatment of COVID-19 acute respiratory distress syndrome: a retrospective, observational study","volume":"206","author":"Franzetti","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0200","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/jcm10040733","article-title":"Adult-onset Still's disease: clinical aspects and therapeutic approach","volume":"10","author":"Tomaras","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2023.105524_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-9236(03)00094-8","article-title":"Pharmacokinetics of anakinra in subjects with different levels of renal function","volume":"74","author":"Yang","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2023.105524_bib0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2020.05.002","article-title":"Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease","volume":"146","author":"Pontali","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jbspin.2023.105524_bib0220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","article-title":"Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease","volume":"80","author":"Banse","year":"2013","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X23000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:30:36Z","timestamp":1761150636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X23000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1297319X23000039"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105524","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2023.105524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105524"}}